DexCom, Inc.
MX ˙ BMV ˙ US2521311074
SecurityMX:DXCM / DexCom, Inc.
InstitutionGlenmede Trust Co Na
Latest Disclosed Ownership288,823 shares
Latest Disclosed Value $ 19,169,181
Glenmede Trust Co Na reports 3,905.31% increase in ownership of DXCM / DexCom, Inc.

On February 17, 2026 - Glenmede Trust Co Na filed a 13F-HR form disclosing ownership of 288,823 shares of DexCom, Inc. (MX:DXCM) valued at $19,169,181 USD as of December 31, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 7,211 shares of DexCom, Inc.. This represents a change in shares of 3,905.31% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F DEXCOM COM 252131107 288,823 281,612 3,905.31 19,169 3,796.14 0.0413
2025-05-15 2025-03-31 13F DEXCOM COM 252131107 7,211 1,118 18.35 492 4.02 0.0026
2025-02-14 2024-12-31 13F DEXCOM COM 252131107 6,093 6,093 474 0.0024
2024-11-13 2024-09-30 13F DEXCOM COM 252131107 0 -5,056 -100.00 0 -100.00
2024-08-14 2024-06-30 13F DEXCOM COM 252131107 5,056 879 21.04 573 -1.04 0.0029
2024-05-15 2024-03-31 13F DEXCOM COM 252131107 4,177 432 11.54 579 24.78 0.0029
2024-02-13 2023-12-31 13F DEXCOM COM 252131107 3,745 -1,274 -25.38 465 -0.85 0.0024
2023-11-14 2023-09-30 13F DEXCOM COM 252131107 5,019 -119 -2.32 468 -21.48 0.0027
2023-08-14 2023-06-30 13F DEXCOM COM 252131107 5,138 0 0.00 597 0.00 0.0034
2023-05-15 2023-03-31 13F DEXCOM COM 252131107 5,138 747 17.01 597 19.92 0.0034
2023-02-14 2022-12-31 13F DEXCOM COM 252131107 4,391 35 0.80 497 42.00 0.0029
2022-11-16 2022-09-30 13F DEXCOM COM 252131107 4,356 4,356 350 0.0022
2021-02-16 2020-12-31 13F DEXCOM COM 252131107 0 -158 -100.00 0 -100.00
2020-11-16 2020-09-30 13F DEXCOM COM 252131107 158 -90 -36.29 65 -34.34 0.0004
2020-08-14 2020-06-30 13F DEXCOM COM 252131107 248 191 335.09 99 725.00 0.0006
2020-05-20 2020-03-31 13F DEXCOM COMMON 252131107 57 0 0.00 12 0.00 0.0001
2020-02-12 2019-12-31 13F DEXCOM COMMON 252131107 57 -123 -68.33 12 -53.85 0.0001
2019-11-14 2019-09-30 13F DEXCOM COMMON 252131107 180 84 87.50 26 85.71 0.0001
2019-08-13 2019-06-30 13F DEXCOM COMMON 252131107 96 0 0.00 14 27.27 0.0001
2019-05-14 2019-03-31 13F DEXCOM COMMON 252131107 96 -4 -4.00 11 0.00 0.0000
2019-02-14 2018-12-31 13F DEXCOM COMMON 252131107 100 68 212.50 11 175.00 0.0001
2018-11-15 2018-09-30 13F DEXCOM COMMON 252131107 32 -16 -33.33 4 -20.00 0.0000
2018-08-15 2018-06-30 13F DEXCOM COMMON 252131107 48 -41 -46.07 5 0.00 0.0000
2018-05-15 2018-03-31 13F DEXCOM COMMON 252131107 89 0 0.00 5 0.00 0.0000
2018-02-15 2017-12-31 13F DEXCOM COMMON 252131107 89 -37 -29.37 5 0.00 0.0000
2017-11-14 2017-09-30 13F DEXCOM COMMON 252131107 126 -15 -10.64 5 -54.55 0.0000
2017-08-14 2017-06-30 13F DEXCOM COMMON 252131107 141 0 0.00 11 0.00 0.0001
2017-05-16 2017-03-31 13F/A-1 DEXCOM COMMON 252131107 141 -57 -28.79 11 10.00 0.0001
2017-05-15 2017-03-31 13F DEXCOM COMMON 252131107 198 10
2017-02-14 2016-12-31 13F DEXCOM COMMON 252131107 198 0 0.00 10 -41.18 0.0001
2016-11-14 2016-09-30 13F/A-1 DEXCOM COMMON 252131107 198 0 0.00 17 13.33 0.0003
2016-11-14 2016-09-30 13F DEXCOM COMMON 252131107 198 15
2016-08-05 2016-06-30 13F DEXCOM COMMON 252131107 198 103 108.42 15 150.00 0.0001
2016-04-28 2016-03-31 13F/A-1 DEXCOM COMMON 252131107 95 -23 -19.49 6 -25.00 0.0000
2016-04-26 2016-03-31 13F DEXCOM COMMON 252131107 95 6
2016-02-11 2015-12-31 13F DEXCOM COMMON 252131107 118 0 0.00 8 -11.11 0.0001
2015-11-12 2015-09-30 13F DEXCOM COMMON 252131107 118 -255 -68.36 9 -67.86 0.0001
2015-07-22 2015-06-30 13F DEXCOM COMMON 252131107 373 -50 -11.82 28 12.00 0.0002
2015-04-29 2015-03-31 13F DEXCOM COMMON 252131107 423 -307 -42.05 25 -35.90 0.0002
2015-02-06 2014-12-31 13F DEXCOM COMMON 252131107 730 255 53.68 39 129.41 0.0003
2014-11-14 2014-09-30 13F DEXCOM COMMON 252131107 475 70 17.28 17 13.33 0.0002
2014-08-13 2014-06-30 13F DEXCOM COMMON 252131107 405 305 305.00 15 275.00 0.0002
2014-05-07 2014-03-31 13F DEXCOM COMMON 252131107 100 0 0.00 4 33.33 0.0000
2014-01-31 2013-12-31 13F DEXCOM COMMON 252131107 100 0 0.00 3 50.00 0.0000
2013-11-14 2013-09-30 13F DEXCOM COMMON 252131107 100 0 0.00 2 0.00 0.0000
2013-08-15 2013-06-30 13F/A-1 DEXCOM COMMON 252131107 100 2
2013-08-20 2013-06-30 13F/A-2 DEXCOM COMMON 252131107 100 100 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.